TOME Clearing Treatment - Dermata Therapeutics, Inc.

Manufacturer
Dermata Therapeutics, Inc.
Effective date
2026-09-10
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-09-22 03:02:45

Label at a glance#

ProductTOME Clearing Treatment
Active ingredientSALICYLIC ACID
Label structure11 sections

Storage and handling

Store at room temperature

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid (0.5%)

OTC - PURPOSE SECTION

Acne Treatment

WARNINGS SECTION

For external use only.If you see signs of extreme redness, stinging, or excessive peeling, wait until your skin recovers to use the product.

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time.
If irritation occurs, only use one topical acne medication at a time.

OTC - WHEN USING SECTION

• Do not get into eyes. If contact occurs, flush thoroughly with
water.
• Do not leave wipe on the skin for an extended period of time.
• If excessive irritation develops or increases, discontinue use and
consult a doctor.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

• Cleanse the skin thoroughly before using this product.
• Cover the affected area once weekly.
• Do not rinse.
• If bothersome dryness or peeling occurs,
reduce the application frequency.

STORAGE AND HANDLING SECTION

Store at room temperature

INACTIVE INGREDIENT SECTION

Aloe Barbadensis Leaf Juice, Caprylyl
Glycol, Citric Acid, Disodium EDTA,
Hamamelis Virginiana (Witch Hazel)
Bark/Leaf/Twig Extract, Lauryl Glucoside,
Menthol, Phenoxyethanol, PPG-5-Ceteth-20,
Sodium Hydroxide, Sodium Lauryl Glucose
Carboxylate, Water

INDICATIONS & USAGE SECTION

• For the treatment of acne
• Reduces the number of acne blemishes and allows skin to heal
• Helps prevent the development of new acne blemishes

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal display panelPrincipal display panel

Clearing Treatment

Once-weekly for acne

TOME

Acne Clearing Treatment

0.5% Salicylic Acid Wipe + Bioneedle™ Mask

• 4 Salicylic Acid Acne Treatment Wipes 0.52 oz (14.7 g)
• 4 Bioneedle™ Cups 0.16 oz (4.4 g)
• 4 Activator Tubes 0.4 f l oz (12 mL)

Natural clearing treatment for acne
Developed to deeply treat the root causes of acne by clearing blemishes, preventing new breakouts,
and reducing the appearance of acne scars

Tome is studied

skincare.


Powered by Bioneedle™


Fast acting and powerful enough to be used once-weekly


Each once-weekly treatment includes: Wipe - Bioneedle™ – Activator – Brush

This box contains 4 weekly treatments,
to be refilled every 4 weeks

Bioneedle Ingredients:

Spongilla lacustrispowder

Activator Ingredients:

Water, Hydrogen Peroxide

For more information about the product and usage instructions, please see product packaging and brochure

Questions?

Visit www.tomeskincare.com

or call 1-800-563-7902

Distributed By:

Dermata Therapeutics, Inc.

Rancho Santa Fe, CA 92067

Made in the U.S.A with globally sourced components

Keep for refills

Dermatologically tested

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Wipe LabelWipe LabelWipe

Salicylic Acid 0.5%

Acne Treatment

TOME 1 Wipe

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87609-10487609-104-01, 87609-104-02, 87609-104-03
87609-105

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BadiagaSPONGILLA LACUSTRISBoiron84636dd0-8f8f-69ee-e053-2991aa0a7ed12023-11-09Name fallback
generic name: SPONGILLA LACUSTRIS
BadiagaSPONGILLA LACUSTRISBoiron6c411fdf-4f32-86d8-e053-2991aa0abb422023-11-09Name fallback
generic name: SPONGILLA LACUSTRIS
Spongilla lacustris MTSPONGILLA LACUSTRISOHM PHARMA INC.a855d4ca-52ed-4e69-93b5-7304bcc84f732021-12-29WarningsName fallback
generic name: SPONGILLA LACUSTRIS

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.